Indeed, DHODH inhibitors such as brequinar and leflunomide exhibit synergistic effects with 5-fluorouracil [48], gemcitabine [49], or doxorubicin [50] on the growth inhibition of cancer cells. The gene discussed is DHODH; the disease is cancer.